North Africa
Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
Amgen will gain antibody technologies designed to discover and develop new molecules with broad applications across therapeutic areas
BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
German biotech company said the acquisition will boost its presence in the US
British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
PMI, which owns a portfolio of tobacco products, announced a deal to acquire Vectura for £927m earlier this week
Philip Morris International to acquire inhaled drug company Vectura for $1.2bn
Vectura is developing inhaled drug delivery solutions for a number of diseases including COVID-19
AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance
AZ first announced the proposed acquisition of Alexion in December 2020
Nordic Capital acquires ADVANZ PHARMA for $846m
ADVANZ PHARMA shareholders to receive $17.26 per share under the terms of the deal
MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals
MorphoSys has also entered into a long-term strategic funding partnership with Royalty Pharma
UK’s Competition and Markets Authority to review AZ/Alexion merger
Proposed acquisition has already received competitions clearance in the US and Canada
Amgen plans acquisition of Rodeo Therapeutics
Deal could be worth over $700m including potential future milestone payments
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities
Sanofi gains access to antibody tech with Kymab acquisition
French pharma will receive global rights to phase 2a monoclonal antibody
